Presented is a label-free biosensor based on a film bulk acoustic resonator (FBAR) to detect one of the cancer markers of alpha-fetoprotein (AFP). The FBAR consisted of a ZnO piezoelectric stack and works near 2.1 GHz. The monoclonal anti-AFP antibody was coated on the surface of the piezoelectric stack as the special bioprobe. Experimental results demonstrate that the FBAR based biosensor can detect AFP antigen successfully without chemical or fluorescent labelling. The minimum detectable AFP concentration of the proposed biosensor is 1 ng/ml with high selectivity. The advantages of this sensor, including the sample fabrication process, ease of detection method, low cost, high sensitive and high-throughput, mean that it has much promise in cancer diagnosis.Introduction: To accurately diagnose and closely monitor complex disease such as cancer, the quantitative detection of multiple serological markers is necessary. In the last few years, there has been growing interest in label-free biosensors using optical and gravimetric systems, such as surface plasmon resonance (SPR) [1], quartz crystal microbalance (QCM) [2], surface acoustic wave (SAW) devices [3] and microcantilevers [4] to detect the presence of specific compounds with selectivity and quantity. Unfortunately, for cancer diagnosis, low-cost, highly sensitive, high-throughput and easily operated technology is still in the developmental stage and requires significant improvements for practical applications.The micromachined monolithic film bulk acoustic resonator (FBAR) makes use of standard silicon technology, and provides low cost and high throughput using a simple electrical detection method with no need of expensive optical apparatus and labelling with fluorescent or adioactive molecules. With a working resonance of 2 to 10 GHz, the FBAR has a minimum detectable mass change in the range of 10 ng/cm 2 , which is several orders of magnitude lower than that of QCM, the working resonance of which is in several megahertz. To date, many attempts to use the FBAR for biochemical applications have been made, with remarkable results [5,6].In the work reported in this Letter, we developed a label-free biosensor based on an FBAR to detect alpha-fetoprotein (AFP). In clinical diagnosis, AFP is a serological marker for hepatocellular carcinoma (HCC), which is the fifth most common cancer and the third leading cause of cancer death worldwide. To enhance the early diagnosis level of HCC, a biosensor applied for AFP detection would better feature the concentration detection limit of less than 10 ng/ml, that is, at ng/ml level [7]. Based on the very low detectable mass change of an FBAR, our FBAR based biosensor can detect the presence of 1 ng/ml AFP antigen successfully.